I

nformation may “want to be free,” as hackers proclaimed in the 1980s, but for anyone who thinks their genetic information is worth more than $0, there is now a middleman.

Genos, a start-up spun out of Complete Genomics, on Thursday unveiled a crowd-sourcing platform where consumers can have their exome sequenced for $499 — and then connect to researchers who’ll pay them up to a couple hundred dollars to use that genetic data in studies. (The exome contains the DNA that codes for the production of proteins, and although it amounts to just 1 percent of the genome, it harbors more than 85 percent of the known variants linked to diseases.)

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy